Trial intelligence / Profile preview

Metoprolol in Hypertrophic Obstructive Cardiomyopathy (TEMPO)

NCT03532802Phase 2Completed

Start
May 2018
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metoprolol in Hypertrophic Obstructive Cardiomyopathy (HOCM). Started May 2018; status: completed.

02

Drugs

metoprolol
03

Conditions

Hypertrophic Obstructive Cardiomyopathy (HOCM)

Beyond the preview

Go deeper on NCT03532802.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03532802.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call